Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Safety|February 21, 2015
Safety of IPX066 , an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's diseaseMeir Kestenbaum, Stanley Fahn
Advances in Neurobiology|March 30, 2017
Clinical Features of LRRK2 Carriers with Parkinson's DiseaseMeir Kestenbaum, Roy N Alcalay
Movement Disorders Clinical Practice|May 19, 2015
Intention Tremor of the Legs in Essential Tremor: Prevalence and Clinical CorrelatesMeir Kestenbaum, Monika Michalec, Qiping Yu, et al.
Scientific Reports|March 4, 2025
Concealment of Parkinsons disease prevalence and impact on health and quality of lifeBadera Naamneh-Abuelhija, Michal Kafri, Meir Kestenbaum, et al.
Journal of Neurologic Physical Therapy : JNPT|November 27, 2024
Utilization of Neurology and Allied Health Services by People With Parkinson's Disease in Israel: A Retrospective Observational StudyBadera Naamneh-Abuelhija, Michal Kafri, Meir Kestenbaum, et al.
The Israel Medical Association Journal : IMAJ|December 10, 2019
Repeated Intravenous Amantadine Infusions in Advanced Parkinsonism: Experience of a Large Movement Disorder CenterMeir Kestenbaum, Muneer Abu Snineh, Tamar Nussbaum, et al.
Journal of the Neurological Sciences|August 3, 2020
Low cerebrospinal fluid volume and the risk for post-lumbar puncture headachesAmgad Droby, Nurit Omer, Tanya Gurevich, et al.
Pageof 3